Predictive value of general movements' quality in low-risk infants for minor neurological dysfunction and behavioural

Anne N Bennema1, Pamela Schendelaar1, Jorien Seggers1

  • 1Division Developmental Neurology,Department of Paediatrics,University Medical Center Groningen,University of Groningen, Hanzeplein 1, Groningen GZ 9713, The Netherlands.

Early Human Development
|February 20, 2016
PubMed

Insights

General movement (GM) assessment in low-risk infants has limited predictive value for minor neurological dysfunction and behavioral issues. While specific abnormal GMs showed some associations, their low sensitivity limits clinical utility for early detection in this population.

Area of Science:

  • Neurodevelopmental Pediatrics
  • Early Childhood Development
  • Movement Assessment

Background:

  • General movement (GM) assessment is established for predicting cerebral palsy in high-risk infants.
  • Its predictive value in low-risk populations for minor neurological dysfunction (MND) and behavioral problems is less understood.

Purpose of the Study:

  • To evaluate the predictive accuracy of early infancy GM quality for complex MND and behavioral issues at preschool age.
  • To determine the clinical utility of GM assessment in a low-risk cohort.

Main Methods:

  • Prospective cohort study of 216 infants from a Groningen Assisted Reproductive Techniques (ART) cohort.
  • GM quality assessed at 2 weeks and 3 months.
  • Minor neurological dysfunction (MND) evaluated at 18 months and 4 years using the Hempel examination; behavioral problems assessed via Child Behavior Checklist at 4 years.

Main Results:

  • Definitely abnormal (DA) GMs at 2 weeks predicted complex MND and atypical total and internalizing problem scores at 4 years (p<0.05).
  • Positive predictive value of DA GMs at 2 weeks was low (13%-60%), but specificity and negative predictive value were high (92%-99%).
  • DA GMs at 3 months were too infrequent for prediction; mildly abnormal (MA) GMs showed no association with outcomes.

Conclusions:

  • GM quality alone has limited clinical value for predicting complex MND and behavioral problems in low-risk children.
  • The low sensitivity of abnormal GMs restricts their use as a sole screening tool in this population.
Abstract

Related Concept Videos